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ABSTRACT
Background: Helicobacter pylori is the most common cause of chronic gastritis in the world, meanwhile 
gastritis caused by non-steroidal anti-inflammatory drugs (NSAIDs) is the most encountered type of gastritis. 
Increased free radicals caused by Helicobacter pylori can cause damage in gastric mucous. Tissue damage 
due to free radicals can be examined by measuring malondialdehyde compound. There are many studies that 
proves the increased malondialdehyde in gastritis, but those studies commonly done in animal experimentation 
and malondialdehyde examination in gastric mucous.
Method: This is a cross-sectional study of 40 dyspepsia patients who came to endoscopic unit of Adam 
Malik General Hospital Medan and networking hospitals by using Rome III criteria. Further examination with 
gastroscopy and biopsy was done to determine gastritis. H. pylori examination was done by using Campylobacter-
like organism test (CLO) test. Serum malondiasldehyde level was examined with high performance liquid 
chromatography (HPLC) method.
Results: From total of 40 patients,24 (60%) were men and 16 (40%) were women with an average age of 47 
years, the majority of the ethnic was Bataknese (57.5%). From 20 patients with H.pylori (+), the average level 
of malondialdehyde was 1.58 umol/mL while in 20 other patients with H. pylori (-), malondialdehyde level was 
1.19 umol/mL with p value 0.013.We found the mean serum levels of malondialdehyde was higher in H. pylori 
positive gastritis than H. pylori negative.
Conclusion: Serum Malondialdehyde level was significantly higher in patient with positive H. pylori gastritis 
compared to H. pylori negative gastritis.
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ABSTRAK
Latar belakang: Helicobacter pylori merupakan penyebab tersering gastritis kronik di seluruh dunia, 
sementara gastritis akibat NSAIDs merupakan penyebab gastritis yang sering dijumpai. Peningkatan radikal 
bebas yang disebabkan Helicobacter pylori mengakibatkan terjadinya kerusakan mukosa gaster. Kerusakan 
jaringan akibat radikal bebas diperiksa dengan mengukur senyawa malondialdehyde. Banyak studi yang 
membuktikan peningkatan malondialdehyde pada gastritis. Namun, penelitian-penelitian tersebut umumnya 
dilakukan pada hewan coba dan pemeriksaan malondialdehyde di mukosa gaster.
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Metode: Penelitian dilakukan dengan desain cross sectional terhadap 40 penderita dispepsia yang datang ke 
unit endoskopi Rumah Sakit H. Adam Malik Medan dan Rumah Sakit jejaring dengan menggunakan kriteria Rome 
III. Selanjutnya dilakukan gastroskopi dan biopsi untuk menentukan adanya gastritis dan pemeriksaan H. pylori 
dengan menggunakan Campylobacter-like organism test (CLO) test. Kadar malondialdehyde serumdiperiksa 
dengan menggunakan metode high performance liqiud chromatography (HPLC).
Hasil: Dari 40 subyek, 24 orang ( 60% ) pria, 16 orang perempuan (40%), rerata umur 47 tahun, mayoritas 
bersuku Batak 23 o rang (57,5%). Pada 20 orang penderita gastritis H. pylori positif didapatkan nilai rerata 
malondialdehyde sebesar 1,58 µmol/mL sedangkan pada 20 penderita gastritis H. pylori negatif yaitu sebesar 
1,19 µmol/mL dengan p 0,013. Ditemukan rerata kadar malondialdehyde serum lebih tinggi pada gastritis H. 
pylori positif dibandingkan gastritis H. pylori negatif (p = 0,013).
Simpulan: Kadar malondialdehyde serum lebih tinggi secara signifikan pada pasien gastritis H. pylori positif 
dibandingkan dengan gastritis H. pylori negatif.
 
Kata kunci: gastritis, Helicobacter pylori, Malondialdehyde.
INTRODUCTION
Gastritis is an inflammation process in gastric 
mucous and submucous as a response to acute or 
chronic injury. Helicobacter pylori infection is the 
most common cause of active chronic gastritis in the 
world, meanwhile chemical gastritis due to NSAID is 
the second most common risk factor in gastritis.1
H. pylori prevalence in the western world keep 
decreasing due to improvement of quality of life, 
good hygiene, lower density, and antibiotic usage. 
Meanwhile in Asia, H. pylori infection rate is very high, 
including Indonesia.2,3 Reactive Oxygen Species that 
was produced by the bacteria is one of many important 
factor whereas oxydative stress has an important 
role in the pathogenesis of worsening gastritis and 
gatric ulcer.4 H. pylori infection will cause neutrofil 
and macrofage/monosit recruitment which in turn 
increase free radical that implied in gastric mucous 
damage. Radical Anion Superoxyde (O2-) resulted 
by neutrofil infiltration to cellular lipid membrane 
which produce lipid peroksidase that metabolized to 
malondialdehyde. Lipid tissue damage due to free 
radical that can be measured with malodialdehyde 
compound measurement which is a lipid peroxidase 
product. Free radical production indirectly measured 
by lipid peroksidase level. Malondialdehyde is a 
biomarker to assess oxydative stress condition.5
Turkkan et al proved that severe chronic 
inflammation correlate with higher malondialdehyde 
level in study subject.6 Navvabi et al that studies H. 
pylori effect on oxydative stress in chronic gastritis 
patient showed that malodialdehyde and oxydised 
glutation level increased significantly in H. pylori 
patient, meanwhile total antioxydant level and reduced 
glutathion significantly decreased.7 Many studies 
have proved the role of free radical to gastritis. But, 
many of these studies usually done in animal and the 
malondialdehyde level was examined from gastric 
mucous. The aim of this study is to compare serum 
malondialdehyde level in H. pylori positive gastritis 
and H. pylori negative gastritis patients. 
METHOD
This is a descriptive analytic study with cross 
sectional design, which is done from April to June 2017 
and was conducted in Endoscopy Unit Adam Malik 
General Hospital Medan and Faculty Medicine of 
Universitas Sumatera Utara. Patients age 18 years and 
older who diagnosed with gastritis from endoscopic 
and histopathologic examinations were enrolled in this 
study. The exclusion criteria were patients who have 
received previous treatment for H. pylori infection in 
the last six months, use of proton pump inhibitor (PPI) 
and H2 receptor antagonist during 2 days before the 
study, and currently on antibiotic theraphy for H. pylori 
eradication, diabetes melitus, hypertension, obesity, 
renal failure, hepatitis, liver cirhossis, coronary artery 
disease, congestive heart failure, rheumatic disease, 
infection diseases, gastrointestinal bleeding, peptic 
ulcer and malignant diseases.
The sample size was determined by using the 
formula of unpaired numerical comparative analytical 
2 groups, with 95% confidence level, 90% power, and 
10% increment to avoid design error, 20 samples are 
needed in each group. With the total sample size is 
40 people.
 Affiliate hospital after approval from ethical 
commission and related institute. Dyspepsia 
patient, defined with Rome III criteria, was then 
examined by using endoscopy and biopsy. To 
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detect H. pylori, serology examination (CLO) was 
done. Malondialdehyde examination was done 
by HPLC examination (high performance liquid 
chromatography). Data was analyzed by using Mann 
Whitney Test with standard deviation (a) 0.05. The data 
was processed and analyzed by using SPSS version 22.
RESULTS
This study include 40 patient that has fulfilled 
inclusion criteria dan divided to two group, each 
with 20 patient in H. pylori (+) gastritis patient and 
20 patient in H. pylori (-) gastritis patient. 24 patient 
(60%) was male and 16 (40%) patient was female with 
average age 48 years old. Median malodndialdehyde 
level was 1.27 ng/mL. Baseline characteristic and 
clinical profile of the subject was showed in Table 1.
DISCUSSION
This study includes 40 patient which has fulfilled 
inclusion criteria and divided into 2 group with 20 
patient each group based on the presence of H. pylori 
infection. Male subject is more commonly found 
in H. pylori (+) gastritis which is 12 (60%) patient 
meanwhile in H. pylori (-) gastritis the amount of male 
and female was the same which is 10 patient (50%). 
This is consistent with Naja F study which include 
1,306 patient where H. pylori positve gastritis was 
more common in male compared to female (56.1% 
: 43.9% ).8 But this is reversed from studies by Zhu 
where from 5,417 sample with H. pylori (+), female 
patient was more frequent than male (64.47:38.26 ).9 
Draker et al studies about reactive oxygen species 
activity and lipid peroksidase in H. pylori gastritis, 
from 161 subject, male patients was more frequent 
than female with average age 47 years old.10
After statistic analysis was done, this study shows 
that average malondialdehyde level was higher in H. 
pylori (+) gastritis which is 1.58 (0.78-2.91) compared 
to H. pylori (-) gastritis which is 1.19 (0.96-2.19). 
Vijayan et al studies shows plasma malondialdehyde 
level in H. pylori patient with anemia increased 
significantly in study group (5.41 ± 2.16 ) compared to 
control group (2.26 ± 0.5; p < 0.05 ).11 This is consistent 
with Santra et al study that shows gastric mucous 
malondialdehyde level in patients with duodenal ulcer 
H. pylori (+) was increased significantly compared to 
H. pylori (-).12
Drake et al states that malondialdehyde level was 
higher significantly in gastritis patient mucous in 
H. pylori patient with chronic gastritis compared to 
normal histology. H. pylori gastritis with more severe 
inflammation has significantly higher malondialdehyde 
level (p <  0.05) and in patient with neutrophil infiltration 
figure 1. Boxplot diagram of Malondialdehyde level in H. pylori 
positive gastritis and H. pylori negative gastritis
Table 1. Baseline characteristic and clinical profile of the 
subject (n = 40)
Characteristic n (%)
Sex
Male
Female
24 (60) a
16 (40)
Age, mean, years 47,85 (14,85) b
Ethnicities
Bataknese
Javanese
Acehnese
23 (57,5) a
11 (27,5)
6 (15)
Religion
Moslem
Christian
Hinduism
24 (60) a
11 (27,5
5 (12,5)
Education level
Elementary school
Junior high school
Senior high school
Bachelor degree
6 (15) a
8 (20)
22 (55)
4 (10)
Jobs
Entrepreneur
Housewife
Employees
Farmer
16 (40) a
12 (30)
10 (25)
2 (5)
Body mass index (BMI), mean, kg/m2
< 18,5
   18,5-24,9
≥ 25
21,53 (3,93) b
2 (5)
38 (95)
0 (0)
Malondyaldehide, median (min-max), µ mol/mL 1,27 (0.78-2.91)c
aCathegorical Data: n(%) b Numeric data, normal distribution: median 
(min – max), cnumeric data, non-normal distribution: median (min-max)
From this data, the mean malondialdehyde level 
in H. pylori (+) patient was 1.58 and the H. pylori (-) 
was 1.19 with p 0.013. This is shown in Table 2 and 
Figure 1.
Table 2. Serum Malondialdehyyde comparison between H. pylori 
positive gastritis and H. pylori negative gastritis
H. pylori (+) H. pylori (-) p
MDA (µmol/mL 
median (min-max) 1.58 (0.78-2.91) 1.19 (0.96-2.19) 0.013*
 *p < 0,05, Mann Whitney U-test
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in grade 2 or 3 gastric mucous has significantly higher 
malondialdehyde compared to normal (p < 0.05).10 
Turkkan proves that more severe chronic inflammation 
has significantly higher malondialdehyde level in study 
subject (p = 0.04).6
Aksoy et al report that average malondialdehyde 
concentration in preeclampsia patient with H pylori 
(+) was significantly higher compared to H. pylori (-). 
Preeclampsia patient has higher serum malondialdehyde 
level compared to healthy pregnant woman, 80% 
preeclampsia women infected by H. pylori, meanwhile 
prevalence of H. pylori infection in healthy pregnant 
woman was 60% (OR = 2.86), so it is suspected that 
increased serum MDA concentration in preeclampsia 
woman was due to H. pylori infection.13
Navvabi et al that studies H. pylori effect to 
oxydative stress in chronic gastritis patient shows that 
malondialdehyde and oxidized glutathione level was 
increased significantly in H. pylori patient, meanwhile 
total antioxidant and reduced glutathione level was 
decreased significantly.7 Khanzode et al that study 
gastritis patient and gastric cancer showed consistent 
result, which is increased serum malondialdehyde 
level significantly in patient with H. pylori infection 
compared to control.14 This study also showed that 
malondialdehyde level was significantly higher in 
gastric cancer patient compared to gastritis.
Up until now, MDA level still didn’t have a normal 
value which can be used as standard. MDA level can 
be affected by age, enzyme activities (superoxide 
dismutase, catalase, and glutathione perioxidase), 
antioxidant supplement (vitamine C, E, βeta-karoten, 
etc), diseases and environment (pollution and 
radiation). Malondialdehyde level as a biomarker to 
assess oxydative stress in each disease was diffferent.15
CONCLUSION
Serum Malondialdehyde level was significantly 
higher in patient with positive H. pylori gastritis 
compared to H. pylori negative gastritis.
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